What is Retractable Technologies?
Retractable Technologies is dedicated to manufacturing and marketing innovative safety medical products designed to prevent needlestick injuries and reduce the risk of healthcare-associated infections. Their flagship product lines include VanishPoint® and Patient Safe® safety medical products, alongside the EasyPoint® needle. The VanishPoint® system features a needle that retracts directly from the patient post-use, thereby minimizing exposure to contaminated sharps. Patient Safe® syringes are engineered to mitigate bloodstream infections linked to catheter hub contamination. The EasyPoint® needle offers versatility, compatible with various syringe types for injections, fluid aspiration, and blood collection, enhancing safety across multiple medical procedures.
How much funding has Retractable Technologies raised?
Retractable Technologies has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Retractable Technologies
PPP
Public-Private Partnership
What's next for Retractable Technologies?
The substantial enterprise-level funding, including the recent strategic investment, positions Retractable Technologies for accelerated expansion and product development. This capital infusion is likely to fuel advancements in their needle-retraction technology and broaden the market reach of their safety-focused medical devices. The company's commitment to addressing critical safety concerns in healthcare suggests a strategic focus on scaling production, enhancing distribution networks, and potentially exploring new product applications to further solidify its role in preventing medical injuries and infections.
See full Retractable Technologies company page
